Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: the experience at Gemelli hospital and a literature review

References

• Anand P, Kunnumakkara AB, Sundaram C, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 2008;25(9):2097-116
   PubMed Web of Science ®Google Scholar
• Gage M, Wattendorf D, Henry LR. Translational advances regarding hereditary breast cancer syndromes. J Surg Oncol 2012;105(5):444-51
   PubMed Web of Science ®Google Scholar
• Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266(5182):66-71
   PubMed Web of Science ®Google Scholar
• Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378(6559):789-92
   PubMed Web of Science ®Google Scholar
• Marsh DJ, Howell VM. The use of denaturing high performance liquid chromatography (DHPLC) for mutation scanning of hereditary cancer genes. Methods Mol Biol 2010;653:133-45
   PubMedGoogle Scholar
• Kwong A, Ng EK, Wong CL, et al. Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis. PLoS One 2012;7(9):e43994
   PubMed Web of Science ®Google Scholar
• Houdayer C, Moncoutier V, Champ J, et al. Enhanced mismatch mutation analysis: simultaneous detection of point mutations and large scale rearrangements by capillary electrophoresis, application to BRCA1 and BRCA2. Methods Mol Biol 2010;653:147-80
   PubMedGoogle Scholar
• Casilli F, Tournier I, Sinilnikova OM, et al. The contribution of germline rearrangements to the spectrum of BRCA2 mutations. J Med Genet 2006;43(9):e49
   PubMed Web of Science ®Google Scholar
• Concolino P, Mello E, Minucci A, et al. Advanced tools for BRCA1/2 mutational screening: comparison between two methods for large genomic rearrangements (LGRs) detection. Clin Chem Lab Med 2014;52(8):1119-27
   PubMed Web of Science ®Google Scholar
• Margulies M, Egholm M, Altman WE, et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005;437(7057):376-80
   PubMed Web of Science ®Google Scholar
• Chan M, Ji SM, Yeo ZX, et al. Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform. J Mol Diagnostics: JMD 2012;14(6):602-12
   PubMed Web of Science ®Google Scholar
• Balabanski L, Antov G, Dimova I, et al. Next-generation sequencing of and in breast cancer patients and control subjects. Molecular and clinical oncology 2014;2(3):435-9
   Google Scholar
• Ruiz A, Llort G, Yague C, et al. Genetic testing in hereditary breast and ovarian cancer using massive parallel sequencing. BioMed Res Int 2014;2014:542541
   PubMed Web of Science ®Google Scholar
• Concolino P, Costella A, Minucci A, et al. A preliminary Quality Control (QC) for next generation sequencing (NGS) library evaluation turns out to be a very useful tool for a rapid detection of BRCA1/2 deleterious mutations. Clin Chim Acta 2014;437:72-7
   PubMed Web of Science ®Google Scholar
• Feliubadalò L, Lopez-Doriga A, Castellsague E, et al. Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes. European journal of human genetics : EJHG 2013;21(8):864-70
   PubMed Web of Science ®Google Scholar
• Engert S, Wappenschmidt B, Betz B, et al. MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases. Hum Mutat 2008;29(7):948-58
   PubMed Web of Science ®Google Scholar
• Sluiter MD, van Rensburg EJ. Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation. Breast Cancer Res Treat 2011;125(2):325-49
   PubMed Web of Science ®Google Scholar
• Rehm HL, Bale SJ, Bayrak-Toydemir P, et al. ACMG clinical laboratory standards for next-generation sequencing. Genet Med 2015;15(9):733-47
   Web of Science ®Google Scholar
• Hehir-Kwa JY, Claustres M, Hastings RJ, et al. Towards a European consensus for reporting incidental findings during clinical NGS testing. Eur J Hum Genet: EJHG 2015. [Epub ahead of print]
   Google Scholar
• Walsh T, Lee MK, Casadei S, et al. Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci USA 2010;107(28):12629-33
   PubMed Web of Science ®Google Scholar
• De Leeneer K, Hellemans J, De Schrijver J, et al. Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations. Hum Mutat 2011;32(3):335-44
   PubMed Web of Science ®Google Scholar
• Michils G, Hollants S, Dehaspe L, et al. Molecular analysis of the breast cancer genes BRCA1 and BRCA2 using amplicon-based massive parallel pyrosequencing. J Mol Diagnostics: JMD 2012;14(6):623-30
   PubMed Web of Science ®Google Scholar
• Ozcelik H, Shi X, Chang MC, et al. Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancer. J Mol Diagnostics: JMD 2012;14(5):467-75
   PubMed Web of Science ®Google Scholar
• Hernan I, Borras E, de Sousa Dias M, et al. Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing. J Mol Diagn: JMD 2012;14(3):286-93
   PubMed Web of Science ®Google Scholar
• Bosdet IE, Docking TR, Butterfield YS, et al. A clinically validated diagnostic second-generation sequencing assay for detection of hereditary BRCA1 and BRCA2 mutations. J Mol Diagn: JMD 2013;15(6):796-809
   PubMed Web of Science ®Google Scholar
• Tarabeux J, Zeitouni B, Moncoutier V, et al. Streamlined ion torrent PGM-based diagnostics: BRCA1 and BRCA2 genes as a model. Eur J Hum Genet: EJHG 2014;22(4):535-41
   PubMed Web of Science ®Google Scholar
• Hirotsu Y, Nakagomi H, Sakamoto I, et al. Detection of BRCA1 and BRCA2 germline mutations in Japanese population using next-generation sequencing. Mol Genet Genomic Med 2015;3(2):121-9
   Google Scholar
• Trujillano D, Weiss ME, Schneider J, et al. Next-generation sequencing of the BRCA1 and BRCA2 genes for the genetic diagnostics of hereditary breast and/or ovarian cancer. J Mol Diagnost: JMD 2015;17(2):162-70
   PubMed Web of Science ®Google Scholar
• Costa JL, Sousa S, Justino A, et al. Nonoptical massive parallel DNA sequencing of BRCA1 and BRCA2 genes in a diagnostic setting. Hum Mutat 2013;34(4):629-35
   PubMed Web of Science ®Google Scholar
• Tung N, Battelli C, Allen B, et al. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer 2015;121(1):25-33
   PubMed Web of Science ®Google Scholar
• Castera L, Krieger S, Rousselin A, et al. Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes. Eur J Hum Genet: EJHG 2014;22(11):1305-13
   PubMed Web of Science ®Google Scholar
• Ledermann J, Harter P, Gourley C, et al. Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial. Lancet Oncol 2014;15(8):852-61
   PubMed Web of Science ®Google Scholar
• Rebbeck TR, Mitra N, Wan F, et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA 2015;313(13):1347-61
   PubMed Web of Science ®Google Scholar
• van Dijk EL, Auger H, Jaszczyszyn Y, Thermes C. Ten years of next-generation sequencing technology. Trends in genetics : TIG 2014;30(9):418-26
   PubMed Web of Science ®Google Scholar
• Bayraktar S, Jackson M, Gutierrez-Barrera AM, et al. Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation Carriers. Breast J 2015;21(3):260-7
   PubMed Web of Science ®Google Scholar
• Zhang J, Fackenthal JD, Zheng Y, et al. Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry. Breast Cancer Res Treat 2012;134(2):889-94
   PubMed Web of Science ®Google Scholar
• Kluska A, Balabas A, Paziewska A, et al. New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing. BMC Med Genomics 2015;8:19
   PubMed Web of Science ®Google Scholar
• D’Argenio V, Esposito MV, Telese A, et al. The molecular analysis of BRCA1 and BRCA2: Next-generation sequencing supersedes conventional approaches. Clin Chim Acta 2015;446:221-5
   PubMed Web of Science ®Google Scholar
• Dacheva D, Dodova R, Popov I, et al. Validation of an NGS Approach for Diagnostic BRCA1/BRCA2 Mutation Testing. Mol Diagn Ther 2015(2):119-30
   PubMed Web of Science ®Google Scholar
• Wong-Brown MW, Meldrum CJ, Carpenter JE, et al. Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer. Breast Cancer Res Treat 2015;150:71-80
   PubMed Web of Science ®Google Scholar
• Hernan I, Mañé B, Borràs E, et al. Two novel frameshift mutations in BRCA2 gene detected by next generation sequencing in a survey of Spanish patients of breast cancer. Clin Transl Oncol 2015(7):576-80
   PubMed Web of Science ®Google Scholar
• Ratajska M, Krygier M, Stukan M, et al. Mutational analysis of BRCA1/2 in a group of 134 consecutive ovarian cancer patients. Novel and recurrent BRCA1/2 alterations detected by next generation sequencing. J Appl Genet 2015;56:193-8
   PubMed Web of Science ®Google Scholar
• Guan Y, Hu H, Peng Y, et al. Detection of inherited mutations for hereditary cancer using target enrichment and next generation sequencing. G Fam Cancer 2015;14:9-18
   PubMed Web of Science ®Google Scholar
• Tung N, Battelli C, Allen B, et al. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer 2015;121(1):25-33
   PubMed Web of Science ®Google Scholar